The greatest biological diversity on the planet, combined with advanced science and the current legal framework in Brazil, offers a unique opportunity for the development of innovative treatments for unmet global medical needs.


Bionovis, a pharmaceutical biotechnology joint venture formed by Aché and three other companies in the Brazilian pharmaceutical market, aims to promote research, development, production and commercialization of biopharmaceuticals in Brazil, being a pioneer in the production of highly complex biological medicines in the country. With the union of public and private efforts, following the most rigorous scientific, technical and ethical standards, in the coming years it will be possible to expand the access of the Brazilian population to highly complex biopharmaceuticals and to develop innovative medicines for Brazil and the world.